WEDNESDAY, Nov. 12, 2025 (HealthDay News) -- For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 recep
Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis
HealthDay1 hrs ago
22
HealthDay1 hrs ago
WEDNESDAY, Nov. 12, 2025 (HealthDay News) -- For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 recep